title: Prevention of stent thrombosis following brachytherapy and implantation of drug-eluting stents.
abstract: The implementation of coronary brachytherapy and especially the application of drug-eluting stents for the prevention of in-stent restenosis are of vital importance in the field of interventional cardiology. Despite undeniable benefits of these new methods a potential increased risk for the occurrence of stent thrombosis as a result of the mode of action of these new methods has to be taken into consideration. The prevention of stent thrombosis following coronary brachytherapy and implantation of drug-eluting stents is therefore of particular importance to assure the success of these forward-looking technologies. This article provides an overview of current data regarding the incidence of stent thrombosis following brachytherapy and implantation of drug-eluting stents and it's implication for clinical practice.
authors.affiliation: Department of Internal Medicine II/Division of Cardiology, University of Vienna, Vienna, Austria.
authors.forename: Michael
authors.initials: M
authors.lastname: Derntl
authors.forename: Bonni
authors.initials: B
authors.lastname: Syeda
authors.forename: Gilbert
authors.initials: G
authors.lastname: Beran
authors.forename: Christoph
authors.initials: C
authors.lastname: Schukro
authors.forename: Stefan
authors.initials: S
authors.lastname: Denk
authors.forename: Dietmar
authors.initials: D
authors.lastname: Glogar
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation; D001918:Brachytherapy / Q000009:adverse effects*; D023903:Coronary Restenosis / Q000517:prevention & control; D003328:Coronary Thrombosis / Q000517:prevention & control*; D016503:Drug Delivery Systems / Q000009:adverse effects*; D006131:Growth Inhibitors / Q000009:adverse effects*; D006801:Humans; D015607:Stents / Q000009:adverse effects*
chemical_list: D006131:Growth Inhibitors